Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

By sjmartinez • February 11, 2023

Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Naeim A, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Cluzet V, Cordisco ME, Cruser D, Ehrhardt S, Forthal D, Fukuta Y, Gawad AL, Gniadek T, Hammel J, Huaman MA, Jabs DA, Jedlicka A, Karlen N, Klein S, Laeyendecker O, Lane K, McBee N, Meisenberg B, Merlo C, Mosnaim G, Park HS, Pekosz A, Petrini J, Rausch W, Shade DM, Shapiro JR, Singleton JR, Sutcliffe C, Thomas DL, Yarava A, Zand M, Zenilman JM, Tobian AAR, Sullivan DJ. Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clin Infect Dis. 2023 Feb 8;76(3):e477-e486. doi: 10.1093/cid/ciac372. PMID: 35579509; PMCID: PMC9129191.

Tags: convalescent plasma, covid-19, Infectious Diseases, post-exposure-prophylaxis, Publications, SARS-CoV-2, transfusion

Reducing excess antibiotic use with rapid tests to distinguish bacterial from nonbacterial causes of respiratory symptoms

Allan-Blitz LT, Klausner JD. Reducing excess antibiotic use with rapid tests to distinguish bacterial from nonbacterial causes of respiratory symptoms. Antimicrob Steward Healthc Epidemiol. 2026[...]

Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections

Allan-Blitz LT, Klausner JD. Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections. Antimicrob Steward Healthc Epidemiol.[...]

Defining and validating an HPV vaccination motivation score in Kenya and Malawi: A tool for use in low- and middle-income countries

Moucheraud C, Li G, Ochieng E, Golub G, Phiri K, Chibaka S, Ganda G, Phiri S, Hyman S, Hoffman RM, Szilagyi PG, Dahlen A. Defining[...]